SLC3A2 and breast carcinoma: Comparative metabolite analysis identified eight metabolites, including leucine, that were downregulated in SLC3A2-KD and SCRIB-KD in ER+ breast cancer cells (Fig. 5k, l), suggesting that SCRIB and SLC3A2 targets leucine uptake in ER+ breast cancer cells.